An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Additionally, a robust market exists on messaging services, where communities with numerous of participants share comparison photos, administration instructions and claims of next-day British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Experts Express Concerns
However, doctors and chemists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.
Several experts said the popularity for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.
Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, advertising, and customer laws, risking fines, prosecution or imprisonment.
Platform Reaction and Content Removal
Based on TikTok, the service has taken down problematic material and banned associated hashtags and query recommendations. The company said it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Research also discovered groups with up to 9,000 participants selling retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, filled with photos of weight loss, positive testimonials and detailed guides for mixing or administering at home.
After moments of joining one group, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.
Item Details and Pricing
Inside these groups, messages show black plastic parcels with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram stated it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these online products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.
Her staff has previously seen patients injured by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to possibly significant medical dangers”.
